Effects of fasting and gender on ochratoxin A toxicokinetics in F344 rats

Food and Chemical Toxicology

Volumn 48, Issue 11, 2010, Pages 3159-3166

  Vettorazzi, A ^a   Troconiz I F ^a   Gonzalez Penas E ^a   Corcuera, L A ^a   Arbillaga, L ^a   Gil, A G ^a   Nagy, J M ^b   Mantle, P G ^b   Lopez de Cerain A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Alpha 2u globulin; Bioavailability; Food; Male and female F344 rat; Ochratoxin A; Toxicokinetic

Indexed keywords

ALPHA 2U GLOBULIN; OCHRATOXIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOOD CONTAMINATION; FOOD INTAKE; GENDER; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN URINE LEVEL; RAT; TOXICOKINETICS;

ALPHA-GLOBULINS; ANIMALS; CARCINOGENS; EATING; FEMALE; FOOD DEPRIVATION; MALE; OCHRATOXINS; RATS; RATS, INBRED F344; SEX FACTORS;

ANIMALIA; RATTUS;

EID: 77957360224     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.08.012     Document Type: Article

References (46)

1. Alvarez L., Gil A.G., Ezpeleta O., Garcia-Jalon J.A., Lopez de Cerain A. Immunotoxic effects of ochratoxin A in Wistar rats after oral administration. Food Chem. Toxicol. 2004, 42:825-834.
2. Aoudia N., Tangni E.K., Larondelle Y. Distribution of ochratoxin A in plasma and tissues of rats fed a naturally contaminated diet amended with micronized wheat fibres: effectiveness of mycotoxin sequestering activity. Food Chem. Toxicol. 2008, 46:871-878.
3. Avantaggiato G., Havenaar R., Visconti A. Assessment of the multi-mycotoxin-binding efficacy of a carbon/aluminosilicate-based product in an in vitro gastrointestinal model. J. Agric. Food. Chem. 2007, 55:4810-4819.
4. Beal S.L., Sheiner L.B. NONMEM Useŕ's guide 1989-2006, Icon Development Solutions, Ellicot City, Maryland, USA.
5. Belmadani A., Tramu G., Betbeder A.M., Steyn P.S., Creppy E.E. Regional selectivity to ochratoxin A, distribution and cytotoxicity in rat brain. Arch. Toxicol. 1998, 72:656-662.
6. Bendele A.M., Carlton W.W., Krogh P., Lillehoj E.B. Ochratoxin A carcinogenesis in the (C57BL/6J X C3H)F1 mouse. J. Natl Cancer Inst. 1985, 75:733-742.
7. Berger V., Gabriel A.F., Sergent T., Trouet A., Larondelle Y., Schneider Y.J. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2). Toxicol. Lett. 2003, 140-141:465-476.
8. Breitholtz-Emanuelsson A., Fuchs R., Hult K. Toxicokinetics of ochratoxin A in rat following intratracheal administration. Nat. Toxins 1995, 3:101-103.
9. Castegnaro M., Mohr U., Pfohl-Leszkowicz A., Esteve J., Steinmann J., Tillmann T., Michelon J., Bartsch H. Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int. J. Cancer 1998, 77:70-75.
10. Denli M., Blandon J.C., Guynot M.E., Salado S., Perez J.F. Efficacy of a new ochratoxin-binding agent (OcraTox) to counteract the deleterious effects of ochratoxin A in laying hens. Poult. Sci. 2008, 87:2266-2272.
11. Diehl K.H., Hull R., Morton D., Pfister R., Rabemampianina Y., Smith D., Vidal J.M., van de Vorstenbosch C. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol. 2001, 21:15-23. European Federation of Pharmaceutical Industries Association and European Centre for the Validation of Alternative Methods.
12. Dietrich D.R., Heussner A.H., O'Brien E. Ochratoxin A: comparative pharmacokinetics and toxicological implications (experimental and domestic animals and humans). Food Addit. Contam. 2005, 22(Suppl 1):45-52.
13. EFSA (European Food Safety Authority), 2006. Opinion of the scientific panel on contaminants in the food chain on a request from the Commission related to ochratoxin A in food. Adopted on 4 April 2006. The EFSA Journal 365, 1-56.
14. Food and Drug Administration, US Department of Health and Human Services, Center for Drug evaluation and research (CDER), 2002. Guidance for industry. Food-effect bioavailability and fed bioequivalence studies.
15. Galtier P., Charpenteau J.L., Alvinerie M., Labouche C. The pharmacokinetic profile of ochratoxin A in the rat after oral and intravenous administration. Drug Metab. Dispos. 1979, 7:429-434.
16. Garrido M.J., Valle M., Calvo R., Troconiz I.F. Altered plasma and brain disposition and pharmacodynamics of methadone in abstinent rats. J. Pharmacol. Exp. Ther. 1999, 288:179-187.
17. Hagelberg S., Hult K., Fuchs R. Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J. Appl. Toxicol. 1989, 9:91-96.
18. Huwig A., Freimund S., Kappeli O., Dutler H. Mycotoxin detoxication of animal feed by different adsorbents. Toxicol. Lett. 2001, 122:179-188.
19. IARC, 1993. Ochratoxin A. Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC Monographs on the evaluation of carcinogenic risks to humans 56, 489-521.
20. 3H]-label from low doses of radioactive ochratoxin A ingested by rats, and evidence for DNA single-strand breaks caused in liver and kidneys. Arch. Toxicol. 1986, 58:219-224.
21. Kumagai S., Aibara K. Intestinal absorption and secretion of ochratoxin A in the rat. Toxicol. Appl. Pharmacol. 1982, 64:94-102.
22. Li S., Marquardt R.R., Frohlich A.A., Vitti T.G., Crow G. Pharmacokinetics of ochratoxin A and its metabolites in rats. Toxicol. Appl. Pharmacol. 1997, 145:82-90.
23. Mantle P., Nagy J. Binding of a ochratoxin A to a urinary globulin: a new concept to account for gender difference in rat nephrocarcinogenic responses. Int. J. Mol. Sci. 2008, 9:719-735.
24. Mantle P., Kulinskaya E., Nestler S. Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A. Food Addit. Contam. 2005, 22(Suppl 1):58-64.
25. Miljkovic A., Pfohl-Leszkowicz A., Dobrota M., Mantle P.G. Comparative responses to mode of oral administration and dose of ochratoxin A or nephrotoxic extract of Penicillium polonicum in rats. Exp. Toxicol. Pathol. 2003, 54:305-312.
26. National Toxicology Program (NTP), 1989. Toxicology and carcinogenesis studies of ochratoxin A (CAS No 303-47-9) in F344/N rats (gavage studies). Nat. l Toxicol. Program Tech. Rep. Ser. 358, 1-142.
27. O'Brien E., Dietrich D.R. Ochratoxin A: the continuing enigma. Crit. Rev. Toxicol. 2005, 35:33-60.
28. OECD Guideline for testing of chemicals, Number 417. Adoped 4 April 1984, Toxicokinetics.
29. Pfohl-Leszkowicz A., Manderville R.A. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 2007, 51:61-99.
30. Pfohl-Leszkowicz A., Petkova-Bocharova T., Chernozemsky I.N., Castegnaro M. Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxins. Food Addit. Contam. 2002, 19:282-302.
31. Rasonyi T., Schlatter J., Dietrich D.R. The role of alpha2u-globulin in ochratoxin A induced renal toxicity and tumors in F344 rats. Toxicol. Lett. 1999, 104:83-92.
32. Ringot D., Chango A., Schneider Y.J., Larondelle Y. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem. Biol. Interact. 2006, 159:18-46.
33. Rodgers I.S., Baetcke K.P. Interpretation of male rat renal tubule tumors. Environ. Health Perspect. 1993, 101(Suppl 6):45-52.
34. Sava V., Reunova O., Velasquez A., Harbison R., Sanchez-Ramos J. Acute neurotoxic effects of the fungal metabolite ochratoxin-A. Neurotoxicology 2006, 27:82-92.
35. Schrickx J., Lektarau Y., Fink-Gremmels J. Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells. Arch. Toxicol. 2006, 80:243-249.
36. Shargel L., Wu-Pong S., Yu A. Applied Biopharmaceutics and Pharmacokinetics 2005, McGraw-Hill Companies Inc. fifth ed.
37. Son W.C., Kamino K., Lee Y.S., Kang K.S. Strain-specific mammary proliferative lesion development following lifetime oral administration of ochratoxin A in DA and Lewis rats. Int. J. Cancer 2003, 105:305-311.
38. Stoev S.D., Daskalov H., Radic B., Domijan A.M., Peraica M. Spontaneous mycotoxic nephropathy in Bulgarian chickens with unclarified mycotoxin aetiology. Vet. Res. 2002, 33:83-93.
39. Suzuki S., Satoh T., Yamazaki M. The pharmacokinetics of ochratoxin A in rats. Jpn. J. Pharmacol. 1977, 27:735-744.
40. Swenberg J.A. Alpha 2u-globulin nephropathy: review of the cellular and molecular mechanisms involved and their implications for human risk assessment. Environ. Health Perspect. 1993, 101(Suppl 6):39-44.
41. Tanaka Y., Slitt A.L., Leazer T.M., Maher J.M., Klaassen C.D. Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice. Biochem. Biophys. Res. Commun. 2005, 326:181-187.
42. Vettorazzi A., Gonzalez-Peñas E., Arbillaga L., Corcuera L.A., Lopez de Cerain A. Simple high-performance liquid chromatography-fluorescence detection method for plasma, kidney and liver of rat as a tool for toxicology studies. J. Chromatogr. A 2008, 1215:100-106.
43. Vettorazzi A., Gonzalez-Peñas E., Troconiz I.F., Arbillaga L., Corcuera L.A., Gil A.G., de Cerain A.L. A different kinetic profile of ochratoxin A in mature male rats. Food Chem. Toxicol. 2009, 47:1921-1927.
44. Wait R., Gianazza E., Eberini I., Sironi L., Dunn M.J., Gemeiner M., Miller I. Proteins of rat serum, urine, and cerebrospinal fluid: VI. Further protein identifications and interstrain comparison. Electrophoresis 2001, 22:3043-3052.
45. WHO (World Health Organisation), 2001. Safety evaluation of certain mycotoxins in food. WHO Food Additives Series, No. 47.
46. Zepnik H., Völkel W., Dekant W. Toxicokinetics of the mycotoxin ochratoxin A in F344 rats after oral administration. Toxicol. Appl. Pharmacol. 2003, 192:36-44.